🇺🇸 FDA
Patent

US 8389734

Amides useful as inhibitors of voltage-gated sodium channels

granted A61PA61P13/02A61P19/02

Quick answer

US patent 8389734 (Amides useful as inhibitors of voltage-gated sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P13/02, A61P19/02, A61P25/02, A61P25/04